Michelle Monje, MD, PhD is a physician-scientist, neuroscientist, and neurooncologist at Stanford University, where she has developed new treatments for brain cancer since 2011. Her interests are neurodevelopment, pediatric gliogenesis, chemobrain, and molecular and cellular (including glial) neurobiology. Her accomplishments are too many to count. She has published numerous high-impact papers (mostly in Cell, Nature, and Science) and won many prestigious awards, including the MacArthur Genius Award (2021) and the NIH Pioneer Award (2018). She is also an HHMI investigator (2021) and a member of the National Academy of Sciences (2025).